Biovica International AB (publ) (STO:BIOVIC.B)
0.5280
+0.0380 (7.76%)
Jul 24, 2026, 5:29 PM CET
Biovica International AB Balance Sheet
Financials in millions SEK. Fiscal year is May - April.
Millions SEK. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Cash & Equivalents | 70.41 | 24.42 | 79.41 | 114.33 | 89.79 |
Cash & Short-Term Investments | 70.41 | 24.42 | 79.41 | 114.33 | 89.79 |
Cash Growth | 188.40% | -69.25% | -30.54% | 27.32% | -38.23% |
Accounts Receivable | 4.72 | 1.82 | 1.67 | 0.58 | 1.13 |
Other Receivables | 2.92 | 2.64 | 4.84 | 3.73 | 2.46 |
Total Trade Receivables | 7.64 | 4.45 | 6.51 | 4.3 | 3.59 |
Inventory | 2.29 | 1.93 | 2.2 | 1.36 | 1.53 |
Total Current Assets | 80.34 | 30.79 | 88.12 | 119.99 | 94.91 |
Net Property, Plant & Equipment | 8.84 | 9.54 | 16.23 | 22.42 | 27.27 |
Other Intangible Assets | 21.72 | 26.54 | 31.6 | 31.6 | 40.35 |
Other Long-Term Assets | 2.53 | 5.7 | 7.15 | 7.34 | 5.46 |
Total Assets | 107.75 | 64.95 | 131.41 | 172.29 | 151.63 |
Accounts Payable | 3.13 | 3.54 | 3.03 | 3.28 | 2.89 |
Accrued Expenses | 10.38 | 10.77 | 20.3 | 15.17 | 6.73 |
Current Portion of Leases | 1.75 | 1.74 | 3.53 | 3.15 | 4.46 |
Unearned Revenue | 1.73 | - | 0.02 | 0.23 | 1.31 |
Other Current Liabilities | 0.91 | 0.93 | 1.41 | 1.81 | 0.71 |
Total Current Liabilities | 18.7 | 18.16 | 28.29 | 23.64 | 16.09 |
Long-Term Leases | - | - | 4.3 | 7.3 | 8.78 |
Other Long-Term Liabilities | 0.96 | 1.85 | 2.18 | 2.71 | 2.67 |
Total Long-Term Liabilities | 2.72 | 3.59 | 6.48 | 10.01 | 11.45 |
Total Liabilities | 21.42 | 21.74 | 34.77 | 33.65 | 27.54 |
Common Stock | 19.46 | 6.52 | 5.6 | 3.05 | 1.9 |
Additional Paid-in Capital | 678.04 | 577.82 | 543.85 | 463.94 | 340.05 |
Accumulated Other Comprehensive Income | -0.39 | -0.22 | 0.41 | 0.12 | 0.12 |
Retained Earnings | -610.78 | -540.92 | -453.23 | -328.47 | -217.97 |
Shareholders' Equity | 86.33 | 43.21 | 96.64 | 138.64 | 124.09 |
Total Liabilities & Equity | 107.75 | 64.95 | 131.41 | 172.29 | 151.63 |
Total Debt | 1.75 | 1.74 | 7.83 | 10.45 | 13.25 |
Net Cash (Debt) | 68.66 | 22.68 | 71.58 | 103.87 | 76.55 |
Net Cash Growth | 202.75% | -68.32% | -31.09% | 35.70% | -46.45% |
Net Cash Per Share | 0.29 | 0.24 | 1.23 | 2.98 | 2.69 |
Book Value | 86.33 | 43.21 | 96.64 | 138.64 | 124.09 |
Book Value Per Share | 0.37 | 0.47 | 1.65 | 3.98 | 4.36 |
Tangible Book Value | 64.61 | 16.67 | 65.04 | 107.03 | 83.74 |
Tangible Book Value Per Share | 0.28 | 0.18 | 1.11 | 3.07 | 2.94 |